Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Zealand Pharma Ord Shs ZLDPF

Healthcare Biotechnology
Zealand Pharma A/S is a Denmark-based biotechnology company. The Company is focused on the discovery, design and development of peptide-based medicines for metabolic and gastrointestinal diseases and other rare disease areas with unmet medical needs. The Company's peptide-based product candidates includes clinical development, registration and, potentially, commercialization. Its pipeline... see more

Recent & Breaking News (PINL:ZLDPF)

Zealand Pharma to Participate in Jefferies London Healthcare Conference

GlobeNewswire November 12, 2021

Zealand Pharma Presents Financial Results for the First Nine Months of 2021; Provides Updates on Commercial Launch and Timing for Congenital Hyperinsulinism and Short Bowel Syndrome Phase Three Clinical Studies

GlobeNewswire November 11, 2021

Zealand Pharma and DEKA Research & Development Corp. Announce Collaboration Agreement to Advance Development of Infusion Pump to Be Used with Dasiglucagon for Treatment of Congenital Hyperinsulinism (CHI)

GlobeNewswire November 5, 2021

Zealand Pharma Announces First Subject Dosed in Phase 1 Trial of Amylin Analogue ZP8396 for the Treatment of Obesity

GlobeNewswire November 4, 2021

Zealand Pharma Hosts Conference Call on November 11 at 4 pm CET (10 am ET) to Present Third Quarter Results for 2021

GlobeNewswire November 4, 2021

Zealand Pharma Announces Presentation of Preclinical Data on Amylin Analogue, ZP8396, and Clinical Data on Glucagon-GLP1 Dual-Agonist, BI 456906, at The Obesity Society Annual Meeting

GlobeNewswire November 1, 2021

Total number of shares and voting rights in Zealand Pharma at September 30, 2021

GlobeNewswire September 30, 2021

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

GlobeNewswire September 10, 2021

Zealand Pharma increases its share capital as a consequence of exercise of employee warrants

GlobeNewswire September 10, 2021

Zealand Pharma Presents Data at 2021 ESPEN Virtual Congress Demonstrating Dose-dependent Effects of Glepaglutide in Both Small and Large Intestines of Animal Models - in Contrast to Short-acting GLP-2

GlobeNewswire September 9, 2021

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

GlobeNewswire September 7, 2021

Zealand Pharma to Participate in Morgan Stanley 19th Annual Global Healthcare Conference

GlobeNewswire September 3, 2021

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

GlobeNewswire September 2, 2021

New Employee Elected Director to the board of Zealand Pharma A/S

GlobeNewswire September 1, 2021

Zealand Pharma to Participate in Goldman Sachs 11th Annual Biotech Symposium

GlobeNewswire August 31, 2021

Total number of shares and voting rights in Zealand Pharma at August 31, 2021

GlobeNewswire August 31, 2021

Zealand Pharma increases its share capital as a consequence of exercise of employee warrants

GlobeNewswire August 20, 2021

Zealand Pharma Announces First Patient Dosed in EASE-SBS 4 Phase 3b Trial Assessing Glepaglutide in Patients with Short Bowel Syndrome

GlobeNewswire August 19, 2021

Employee Elected Director to step down from the board of Zealand Pharma A/S

GlobeNewswire August 13, 2021

Zealand Pharma Launches ZEGALOGUE® (dasiglucagon) Injection and Advances Pipeline Programs Across Multiple Therapeutic Areas

GlobeNewswire August 12, 2021